This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.
Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.
| Document | Type | Information Source | |
|---|---|---|---|
| XOFIGO Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XOFLUZA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XOFLUZA Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| XOLAIR 150 mg Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XOLAIR 75 mg Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XOLREMDI Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| XOMOLIX Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| XOPENEX Inhalation solution | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| XOROX Eye ointment | MPI, EU: SmPC | Medicines Authority (MT) | |
| XOSPATA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XOSPATA Tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| XOTERNA BREEZHALER Inhalation powder, hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.